Cygler, 41, will replace Pascal Prigent who was appointed vice-president of Vaccines Commercial Strategy of GSK US Pharmaceuticals.
Cygler, whose experience in the pharmaceuticals industry spans over 15 years, joined GSK Romania in April 2012, as Business Unit Director for the Retail division. Subsequently, she was appointed Specialty Care Business Unit Director.
In her new position of general manager of GSK Romania, Cygler will be tasked with developing GSK’s pharmaceuticals division.
Cygler said she is already familiar with the main problems the Romanian healthcare sector is facing and pledged to continue GSK’s efforts aimed to increase patients’ access to innovating treatments.
GSK Romania imports, distributes and produces medication. The company put its production unit in Brasov, central Romania, up for sale mid-2013. In December, GSK said it would select a buyer in the first quarter of 2014. If it fails to sell the factory, GSK plans to shut it down in 2015.
According to Cegedim data, GSK ranked sixth on the local pharmaceuticals market in 2013, with sales of RON552.6 million and a market share of 4.7%.